The Metformin–Exercise Paradox: New Evidence of a Potential Trade-Off

Metformin has long been considered one of the most important medications for managing type 2 diabetes and improving insulin sensitivity. In recent years, it has also attracted attention as a potential "healthy aging" drug. But a growing body of research is raising an important question: could metformin interfere with some of the benefits of exercise?

Several studies over the past decade have reported that people taking metformin may experience smaller improvements in aerobic fitness, insulin sensitivity, and muscle adaptations compared with people who exercise without the drug. More recently, Etayo-Urtasun et al (2026) conducted a meta-analysis of controlled trials and found that combining metformin with structured exercise was associated with reduced gains in cardiorespiratory fitness and blood pressure improvements. Researchers also reported no evidence that metformin enhanced exercise outcomes.

New mechanistic research is helping explain why. Scientists have observed that metformin may suppress some of the mitochondrial and genetic responses normally triggered by exercise. Because these cellular adaptations are thought to drive improvements in endurance and metabolic health, dampening them could reduce the body's training response.

However, the story is far from settled. Metformin remains a highly effective and well-studied treatment for people with diabetes and prediabetes. Some studies continue to find important health benefits from the drug, and researchers emphasize that patients should not stop taking prescribed metformin based on these findings alone.

The emerging evidence highlights a broader lesson in medicine: interventions that are beneficial on their own do not always produce additive benefits when combined. As researchers continue to study the interaction between exercise and metformin, future guidelines may help identify who benefits most from each intervention, and whether timing or dosing strategies can reduce potential conflicts.

For now, exercise remains one of the most powerful tools for improving health, and metformin remains an important therapy for millions of people. The challenge is understanding how to optimize both.

Etayo-Urtasun P, Sáez de Asteasu ML, Izquierdo M. (2026). The effects of metformin and exercise training on cardiorespiratory, blood pressure, and metabolic adaptations across the spectrum of glucose dysregulation: a systematic review and meta-analysis. https://doi.org/10.1016/j.eclinm.2026.103915   

Steven K Malin, Emily M Heiston, Daniel J Battillo, Tristan J Ragland, Andrew J Gow, Sue A Shapses, Ankit M Shah, James T Patrie, Eugene J Barrett, Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 111, Issue 4, April 2026, Pages e1124–e1135, https://doi.org/10.1210/clinem/dgaf551